C
-
Chronic hepatitis C
Health-Related Quality of Life after Direct Acting Antiviral Treatment for Chronic Hepatitis C in a community Led Program [7.2, Issue 2, 2023, Pages 9-14]
-
Chronic liver disease
Impact of COVID-19 on mortality rate in patients with chronic liver diseases, single-centre observational study [7.2, Issue 2, 2023, Pages 15-22]
-
COVID-19
Impact of COVID-19 on mortality rate in patients with chronic liver diseases, single-centre observational study [7.2, Issue 2, 2023, Pages 15-22]
D
-
DAA Treatment
Health-Related Quality of Life after Direct Acting Antiviral Treatment for Chronic Hepatitis C in a community Led Program [7.2, Issue 2, 2023, Pages 9-14]
H
-
Health related quality of life
Health-Related Quality of Life after Direct Acting Antiviral Treatment for Chronic Hepatitis C in a community Led Program [7.2, Issue 2, 2023, Pages 9-14]
-
Hepatic artery resistive index
Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases [7.2, Issue 2, 2023, Pages 1-8]
L
-
Liver stiffness measurement
Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases [7.2, Issue 2, 2023, Pages 1-8]
N
-
NAFLD fibrosis score
Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases [7.2, Issue 2, 2023, Pages 1-8]
-
Nonalcoholic fatty liver disease
Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases [7.2, Issue 2, 2023, Pages 1-8]
Your query does not match with any item